# Management of Mandibular ORN: PENTO as Medical Treatment

> **NCT02368457** · PHASE4 · COMPLETED · sponsor: **Hospital Vall d'Hebron** · enrollment: 24 (actual)

## Conditions studied

- Osteoradionecrosis

## Interventions

- **DRUG:** Pentoxifylline and Tocopherol

## Key facts

- **NCT ID:** NCT02368457
- **Lead sponsor:** Hospital Vall d'Hebron
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-02
- **Final completion:** 2018-01-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02368457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02368457, "Management of Mandibular ORN: PENTO as Medical Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02368457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*